Measurement of the anatomic position of the corrugator supercilii

Dermatologic Surgery

Volumn 31, Issue 8 PART 1, 2005, Pages 923-927

  Benedetto, Anthony V ^a,b,e   Lahti, James G ^c,d  

^a Dermatologic SurgiCenter   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Dermatology Partners of the North Shore   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CADAVER; COMPARATIVE STUDY; CORRUGATOR SUPERCILII; FACE MUSCLE; FEMALE; HUMAN; MALE; MEDICAL RESEARCH; PRIORITY JOURNAL; STUDENT T TEST; CUTANEOUS PARAMETERS; EYEBROW; EYELID; GENDER IDENTITY; HISTOLOGY; PATHOLOGY; SKIN DISEASE;

CADAVER; EYEBROWS; EYELIDS; FACIAL DERMATOSES; FACIAL MUSCLES; FEMALE; GENDER IDENTITY; HUMANS; MALE; SKIN AGING;

EID: 24044525313     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2005.31806     Document Type: Article

References (17)

1. Pierard GE, LaPiere CM. The microanatomical basis of facial frown lines. Arch Dermatol 1989;125:1090-2.
2. Carruthers AJ, Lowe NJ, Menter MA, et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 2002;46:840-9.
3. Lowe NJ, Maxwell A, Harper H. Botulinum A exotoxin for glabellar folds: a double-blind, placebo-controlled study with an electromyographic injection technique. J Am Acad Dermatol 1996;35:569-72.
4. Carruthers JDA, Carruthers JA. Treatment of glabellar frown lines with C-botulinum-A exotoxin. J Dermatol Surg Oncol 1992;18:17-21.
5. DasGupta BR, Sugiyama H. A common subunit structure in Clostridium botulinum type A, B and E toxins. Biochem Biophys Res Commun 1972;48:108-12.
6. Macdonald MR, Spiegel JH, Raven RB, et al. An anatomical approach to glabellar rhytids. Arch Otolaryngol Head Neck Surg 1998;124:1315-20.
7. Carruthers A, Kiene K, Carruthers J. Botulinum A exotoxin use in clinical dermatology. J Am Acad Dermatol 1996;34:788-94.
8. Cook BE Jr, Lucarelli MJ, Lemke BN. Depressor supercilii muscle: anatomy, histology, and cosmetic implications. Ophthalmol Plast Reconstr Surg 2001;17:404-11.
9. Dutton JJ. Atlas of clinical and surgical orbital anatomy. Philadelphia: W.B.Saunders; 1994.
10. Gray's anatomy: the anatomical basis of medicine and surgery. 37th ed. Edinburgh: Churchill Livingstone; 1995.
11. Kimura K. Foramina and noches on the supraorbital margin in some racial groups. Acta Anat 1977;52:203-9.
12. Berry AC. Factors affecting the incidence of non-metrical skeletal variants. J Anat 1975;120:519-35.
13. Carruthers A, Carruthers J. Botulinum toxin type A: history and current cosmetic use in the upper face. Semin Cutan Med Surg 2001;20:71-84.
14. Edelstein C, Shorr N, Jacobs J, et al. Oculoplastic experience with the cosmetic use of botulinum A exotoxin. Dermatol Surg 1998;24:1208-12.
15. Klein AW, Mantell A. Electromyographic guidance in injecting botulinum toxin. Dermatol Surg 1998;24:1184-6.
16. Binder WJ, Blitzer A, Brin MF. Treatment of hyperfunctional lines of the face with botulinum toxin A. Dermatol Surg 1998;24:1198-205.
17. Carruthers J, Carruthers A. Botulinum A exotoxin in clinical ophthalmology. Can J Ophthalmol 1996;30:389-400.